company background image
80R logo

AroCell DB:80R Stock Report

Last Price

€0.026

Market Cap

€7.7m

7D

-6.6%

1Y

-5.2%

Updated

22 Dec, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

AroCell AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for AroCell
Historical stock prices
Current Share PriceSEK 0.026
52 Week HighSEK 0.052
52 Week LowSEK 0.017
Beta1.33
1 Month Change0%
3 Month Change-35.03%
1 Year Change-5.19%
3 Year Change-67.14%
5 Year Change-77.54%
Change since IPO-94.27%

Recent News & Updates

Recent updates

Shareholder Returns

80RDE Life SciencesDE Market
7D-6.6%-3.1%-2.0%
1Y-5.2%-5.9%6.9%

Return vs Industry: 80R matched the German Life Sciences industry which returned -5.9% over the past year.

Return vs Market: 80R underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 80R's price volatile compared to industry and market?
80R volatility
80R Average Weekly Movement25.5%
Life Sciences Industry Average Movement7.1%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 80R's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 80R's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200022Anders Hultmanwww.arocell.com

AroCell AB (publ), a vitro diagnostics company, develops and markets blood and urine sample test products for use in the treatment of breast, prostate, and bladder cancers. The company provides AroCell TK 210 ELISA, an immunoassay kit for the determination of human Thymidine Kinase 1 protein concentration in blood samples; and UBC Rapid for diagnosing and monitoring bladder cancer patients. It also offers TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever.

AroCell AB (publ) Fundamentals Summary

How do AroCell's earnings and revenue compare to its market cap?
80R fundamental statistics
Market cap€7.69m
Earnings (TTM)-€4.40m
Revenue (TTM)€4.48m

1.7x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
80R income statement (TTM)
RevenueSEK 51.58m
Cost of RevenueSEK 45.11m
Gross ProfitSEK 6.47m
Other ExpensesSEK 57.05m
Earnings-SEK 50.57m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 19, 2025

Earnings per share (EPS)-0.22
Gross Margin12.55%
Net Profit Margin-98.04%
Debt/Equity Ratio0%

How did 80R perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:43
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AroCell AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oscar BergmanRedeye